Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative DiscographyConclusions Illustrate Nociscan Saves $1,712 per Patient and Improves ...

该公司的技术专注于为患有慢性腰痛的患者提供护理。 Aclarion的股票在纳斯达克挂牌交易。 Aclarion的股票代码是什么？ Aclarion的股票代码是“ACON。” Aclarion的市值是多少？ 截至今天，Aclarion的市值是4.45M。

WASHINGTON, April 3, 2025 /PRNewswire/ -- ACON Investments ("ACON"), today announced the sale of its equity interests in Kept Companies, Inc. ("Kept" or the "Company") to affiliates of DFW Capital ...

Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025BROOMFIELD, Colo., April 09, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The fast and social code editor.

What's your call on Solar Ind today?

Copyright © 2025 MarketWatch, Inc. All rights reserved.